Skip to content

Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder

Computerized Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01463137
Acronym
SOFIE-11
Enrollment
129
Registered
2011-11-01
Start date
2011-10-31
Completion date
2013-01-31
Last updated
2016-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Phobia

Keywords

social phobia, anxiety

Brief summary

A study investigating six different versions of a computerized attention bias modification internet program in the treatment of social phobia / social anxiety disorder.

Detailed description

Previous studies have shown that individuals with social phobia have attention biases, often focusing on aversive stimuli or avoiding aversive stimuli. Computerized training programs have been developed to implicitly direct the users attention towards a neutral, non-threatening stimuli. In this study, such a program will be compared with a program that implicitly directs the users' attention towards threatening cues. Pre/post-measurements will be compared in a sample of individuals that meet diagnostic criteria of Social Anxiety Disorder. Participants will be randomized to one of three groups, receiving one of the two variants of the attention bias modification program or a control training program.

Interventions

BEHAVIORALAttention bias modification

All arms will consist of 10 minutes of training in front of a computer screen (192 trials) once a day for 14 days.

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Participants must meet criteria for social phobia using the International classification system Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). * Comorbidity is allowed, but social phobia must be the primary diagnosis.

Exclusion criteria

* Below 18 years old. * Individuals who are suicide prone will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in Liebowitz Social Anxiety Scale self rated versionpretreatment (week 0), post treatment (week 2), 4 month follow-upChange from baseline in social anxiety symptoms expected between time frames.

Secondary

MeasureTime frameDescription
Change from baseline in Social Phobia Screening QuestionnairePretreatment (week 0), post treatment (week 2), 4 month follow-upSocial Phobia Screening Questionnaire (SPSQ), diagnostic tool for social phobia. Change from baseline in social anxiety symptoms expected between time frames.
Change from baseline in Social Interaction Anxiety Scale (SIAS)Pretreatment (week 0), post treatment (week 2), 4 month follow-upChange from baseline in social anxiety symptoms expected between time frames.
Change from baseline in Social Phobia Scale (SPS)Pretreatment (week 0), post treatment (week 2), 4 month follow-upChange from baseline in social anxiety symptoms expected between time frames.
Change from baseline in Montgomery Åsberg Depression Rating Scale (MADRS-S)Pretreatment (week 0), post treatment (week 2), 4 month follow-upMeasure depression. Change from baseline in depressive symptoms expected between time frames.
Change from baseline in Quality of Life Inventory (QOLI)Pretreatment (week 0), post treatment (week 2), 4 month follow-upMeasure quality of life. Change from baseline in quality of life expected between time frames.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026